United States Specialty Generics Market Report 2022: Sector to Reach $43.1 Billion by 2027 at a 10.56% CAGR - ResearchAndMarkets.com

The "United States Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

The United States specialty generics market size reached US$ 23.6 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 43.1 Billion by 2027, exhibiting a CAGR of 10.56% during 2021-2027.

Specialty generic drugs are the generic versions of specialty branded drugs once they lose patent protection. These drugs are used to treat life threatening and serious health conditions such as cancer, autoimmune diseases, epilepsy, HIV, hepatitis, multiple sclerosis, rheumatoid arthritis, etc.

Specialty generics are economical compared to specialty drugs as they don't need to undergo the costly and time-consuming research and development procedures required for their branded versions. Moreover, marketing and promotional expenses for speciality generics are also lower compared to their branded versions. This results in significant savings for patients, government and healthcare providers. Moreover, the market is also being catalysed by a rising ageing population in the United States.

This has resulted in an increasing prevalence of various life-threatening diseases such as cancer, multiple sclerosis, hepatitis, HIV, autoimmune disease, etc. For instance, the American cancer society estimated a total of 1,762,450 new cancer cases and 606,880 deaths from cancer in the United States for 2019. Additionally, the patent expiration of several blockbuster branded specialty drugs is further expected to catalyse the market growth in the coming years.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the United States specialty generics market report, along with forecasts for the period 2022-2027. Our report has categorized the market based on route of administration, therapeutic application and distribution channel.

Breakup by Route of Administration:

• Injectables
• Oral
• Others

Breakup by Therapeutic Application:

• Oncology
• Hepatitis
• Multiple Sclerosis
• HIV
• Other Autoimmune Diseases
• Others

Breakup by Distribution channel:

• Retail Pharmacies
• Specialty Pharmacies
• Hospital Pharmacies

Competitive Landscape:

The leading players in the US specialty generics industry have also been examined in the report.

Key Questions Answered in This Report

1. What was the size of the United States specialty generics market in 2021?

2. What is the expected growth rate of the United States specialty generics market during 2022-2027?

3. What are the key factors driving the United States specialty generics market?

4. What has been the impact of COVID-19 on the United States specialty generics market?

5. What is the breakup of the United States specialty generics market based on the route of administration?

6. What is the breakup of the United States specialty generics market based on the therapeutic application?

7. What is the breakup of the United States specialty generics market based on the distribution channel?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Global Specialty Generics Market: Introduction

5 Why are Specialty Generics So Lucrative?

6 Global Specialty Generics Market

7 US Specialty Generics Market

8 Market Breakup by Route of Administration

9 Market Breakup by Therapeutic Application

10 Market Breakup by Distribution Channel

11 Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/r/27pxrb

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230309005433/en/